跳至主要内容
临床试验/NCT01987674
NCT01987674终止1 期

Impact of a Pre-meal Protein Drink on Metabolic Markers and Glycemic Control in Patients With Type 2 Diabetes

Lund University1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
终止
入组人数
35
试验地点
1
主要终点
HbA1c

研究概览

简要总结

The purpose of this study is to investigate if a pre-meal drink containing proteins can positively influence glycaemic control in patients with type 2 diabetes mellitus. Comparison with a placebo is included.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •diagnosed type 2 diabetes mellitus according to WHO criteria (1999)
  • •age between 30-80 years
  • •non well controlled diabetes with HbA1c-levels above 62 mmol/mol

排除标准

  • •pregnant or risk of becoming pregnant
  • •severe disease
  • •psychological disease, dementia or mental disability that makes it impossible to retrieve informed consent of participation
  • •liver disease
  • •kidney malfunction (GFR <60 or aspartate transaminase (ASAT)/alanine transaminase (ALT) two times higher than the normal interval

研究组 & 干预措施

Pre-meal protein drink

Experimental

A dose of 100 ml is taken just before breakfast, lunch and dinner.

干预措施: Pre-meal protein drink (Dietary Supplement)

Water drink

Placebo Comparator

A dose of 100 ml is taken just before breakfast, lunch and dinner.

干预措施: Water drink (Other)

结局指标

主要结局

HbA1c

时间窗: 16 weeks

Glycated hemoglobin

次要结局

  • Postprandial glycemia(16 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Elin Östman

Associate professor

Lund University

研究点 (1)

Loading locations...

相似试验